Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia

Neuroscience

Volumn 242, Issue , 2013, Pages 39-52

  Chen, C H ^a   Huang, S Y ^a   Chen, N F ^b   Feng, C W ^a   Hung, H C ^a   Sung, C S ^c   Jean, Y H ^d   Wen, Z H ^a   Chen, W F ^e  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Astrocyte; Hematopoietic growth factor; Microglia; Neurodegenerative disease

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; NEUROTROPHIC FACTOR; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; GLIA CELL; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD ISCHEMIA; UPREGULATION;

ANIMALS; ASTROCYTES; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE COLONY-STIMULATING FACTOR; INJECTIONS, SPINAL; ISCHEMIA; MALE; MICROGLIA; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877043428     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.02.017     Document Type: Article

References (127)

1. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002, 3:383-394.
2. Arvidsson A., Kokaia Z., Airaksinen M.S., Saarma M., Lindvall O. Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain. Neuroscience 2001, 106:27-41.
3. Aubert I., Ridet J.L., Gage F.H. Regeneration in the adult mammalian CNS: guided by development. Curr Opin Neurobiol 1995, 5:625-635.
4. Barreto G., White R.E., Ouyang Y., Xu L., Giffard R.G. Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 2011, 11:164-173.
5. Bartolini A., Vigliani M.C., Magrassi L., Vercelli A., Rossi F. G-CSF administration to adult mice stimulates the proliferation of microglia but does not modify the outcome of ischemic injury. Neurobiol Dis 2011, 41:640-649.
6. Bensinger W., Singer J., Appelbaum F., Lilleby K., Longin K., Rowley S., Clarke E., Clift R., Hansen J., Shields T., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993, 81:3158-3163.
7. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98.
8. Boer K., Troost D., Spliet W.G., van Rijen P.C., Gorter J.A., Aronica E. Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol 2008, 115:683-696.
9. Bouhy D., Malgrange B., Multon S., Poirrier A.-L., Scholtes F., Schoenen J., Franzen R. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 2006, 20:1239-1241.
10. Buffo A., Rite I., Tripathi P., Lepier A., Colak D., Horn A.P., Mori T., Gotz M. Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 2008, 105:3581-3586.
11. Cacalano G., Fariñas I., Wang L.-C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A.M., Reichardt L.F., Hynes M., Davies A., Rosenthal A. GFR±1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 1998, 21:53-62.
12. Cashman N., Tan L.-Y., Krieger C., Mädler B., Mackay A., Mackenzie I., Benny B., Nantel S., Fabros M., Shinobu L., Yousefi M., Eisen A. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 2008, 37:620-625.
13. Chen W.F., Jean Y.H., Sung C.S., Wu G.J., Huang S.Y., Ho J.T., Su T.M., Wen Z.H. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways. Neuroscience 2008, 153:31-43.
14. Chen B., Gao X.Q., Yang C.X., Tan S.K., Sun Z.L., Yan N.H., Pang Y.G., Yuan M., Chen G.J., Xu G.T., Zhang K., Yuan Q.L. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 2009, 1284:1-11.
15. Chen W.F., Sung C.S., Jean Y.H., Su T.M., Wang H.C., Ho J.T., Huang S.Y., Lin C.S., Wen Z.H. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters. Neuroscience 2010, 165:1217-1232.
16. Choi J.-S., Kim H.-Y., Cha J.-H., Choi J.-Y., In Park S., Jeong C.H., Jeun S.-S., Lee M.-Y. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J Histochem Cytochem 2007, 55:821-830.
17. Chou A.K., Yang L.C., Wu P.C., Wong W.T., Liu G.S., Chen J.T., Howng S.L., Tai M.H. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia. Brain Res Mol Brain Res 2005, 133:198-207.
18. Coyle D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 1998, 23:75-83.
19. De Leo J.A., Tawfik V.L., LaCroix-Fralish M.L. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122:17-21.
20. Deng L.X., Hu J., Liu N., Wang X., Smith G.M., Wen X., Xu X.M. GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol 2011, 229:238-250.
21. Dhondt J., Peeraer E., Verheyen A., Nuydens R., Buysschaert I., Poesen K., Van Geyte K., Beerens M., Shibuya M., Haigh J.J., Meert T., Carmeliet P., Lambrechts D. Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons. FASEB J 2011, 25:1461-1473.
22. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., Bohn M., Poser W., Ruther E., Kochen M., Gefeller O., Gleiter C., Wessel T.C., De Ryck M., Itri L., Prange H., Cerami A., Brines M., Siren A.L. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002, 8:495-505.
23. Enomoto H., Araki T., Jackman A., Heuckeroth R.O., Snider W.D., Johnson E.M., Milbrandt J. GFR±1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 1998, 21:317-324.
24. Falk T., Yue X., Zhang S., McCourt A.D., Yee B.J., Gonzalez R.T., Sherman S.J. Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. Neurosci Lett 2011, 496:43-47.
25. Fernández-López D., Faustino J., Derugin N., Wendland M., Lizasoain I., Moro M.A., Vexler Z.S. Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke. Neuroscience 2012, 207:307-315.
26. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
27. Gao Y.J., Ji R.R. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7:482-493.
28. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003, 9:589-595.
29. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem Int 1994, 25:227-233.
30. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
31. Ha Y., Kim Y.S., Cho J.M., Yoon S.H., Park S.R., Yoon D.H., Kim E.Y., Park H.C. Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J Neurosurg Spine 2005, 2:55-61.
32. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 2007, 13:54-63.
33. Hasselblatt M., Jeibmann A., Riesmeier B., Maintz D., Schabitz W.R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol 2007, 113:45-51.
34. Heneka M.T., Rodriguez J.J., Verkhratsky A. Neuroglia in neurodegeneration. Brain Res Rev 2010, 63:189-211.
35. Hermann D.M., Kilic E., Kugler S., Isenmann S., Bahr M. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis 2001, 8:655-666.
36. Herrera J.J., Nesic O., Narayana P.A. Reduced vascular endothelial growth factor expression in contusive spinal cord injury. J Neurotrauma 2009, 26:995-1003.
37. Horita Y., Honmou O., Harada K., Houkin K., Hamada H., Kocsis J.D. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 2006, 84:1495-1504.
38. Ibanez C.F. Beyond the cell surface: new mechanisms of receptor function. Biochem Biophys Res Commun 2010, 396:24-27.
39. Iwase T., Jung C.G., Bae H., Zhang M., Soliven B. Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J Neurochem 2005, 94:1488-1499.
40. Jean Y.H., Chen W.F., Sung C.S., Duh C.Y., Huang S.Y., Lin C.S., Tai M.H., Tzeng S.F., Wen Z.H. Capnellene, a natural marine compound derived from soft coral, attenuates chronic constriction injury-induced neuropathic pain in rats. Br J Pharmacol 2009, 158:713-725.
41. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci 2000, 97:10242-10247.
42. Jung K.-H., Chu K., Lee S.-T., Kim S.-J., Sinn D.-I., Kim S.U., Kim M., Roh J.-K. Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res 2006, 1073-1074:190-201.
43. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Phys Rev 2011, 91:461-553.
44. Kim H.M., Hwang D.H., Lee J.E., Kim S.U., Kim B.G. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PloS One 2009, 4:e4987.
45. Kim N.K., Choi B.H., Huang X., Snyder B.J., Bukhari S., Kong T.-H., Park H., Park H.C., Park S.R., Ha Y. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. Eur J Neurosci 2009, 29:891-900.
46. Kitagawa H., Hayashi T., Mitsumoto Y., Koga N., Itoyama Y., Abe K. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 1998, 29:1417-1422.
47. Kitagawa H., Sasaki C., Zhang W.R., Sakai K., Shiro Y., Warita H., Mitsumoto Y., Mori T., Abe K. Induction of glial cell line-derived neurotrophic factor receptor proteins in cerebral cortex and striatum after permanent middle cerebral artery occlusion in rats. Brain Res 1999, 834:190-195.
48. Klein S.M., Behrstock S., McHugh J., Hoffmann K., Wallace K., Suzuki M., Aebischer P., Svendsen C.N. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005, 16:509-521.
49. Kobayashi T., Ahlenius H., Thored P., Kobayashi R., Kokaia Z., Lindvall O. Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats. Stroke 2006, 37:2361-2367.
50. Kong T., Choi J.K., Park H., Choi B.H., Snyder B.J., Bukhari S., Kim N.K., Huang X., Park S.R., Park H.C., Ha Y. Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation. J Neurosurg 2009, 111:155-163.
51. Korzus E., Nagase H., Rydell R., Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 1997, 272:1188-1196.
52. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
53. Krum J.M., Mani N., Rosenstein J.M. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002, 110:589-604.
54. Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 2008, 212:108-117.
55. Ledda F., Paratcha G., Sandoval-Guzman T., Ibanez C.F. GDNF and GFR[alpha]1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat Neurosci 2007, 10:293-300.
56. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115:71-83.
57. Lennmyr F., Ata K.A., Funa K., Olsson Y., Terént A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 1998, 57:874-882.
58. Li Y., Zhang F., Nagai N., Tang Z., Zhang S., Scotney P., Lennartsson J., Zhu C., Qu Y., Fang C., Hua J., Matsuo O., Fong G.H., Ding H., Cao Y., Becker K.G., Nash A., Heldin C.H., Li X. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 2008, 118:913-923.
59. Lin Y.C., Huang S.Y., Jean Y.H., Chen W.F., Sung C.S., Kao E.S., Wang H.M., Chakraborty C., Duh C.Y., Wen Z.H. Intrathecal lemnalol, a natural marine compound obtained from Formosan soft coral, attenuates nociceptive responses and the activity of spinal glial cells in neuropathic rats. Behav Pharmacol 2011, 22:739-750.
60. Liu W., Wang C.-H., Cui Y., Mo L.-Q., Zhi J.-L., Sun S.-N., Wang Y.-L., Yu H.-M., Zhao C.-M., Feng J.-Q., Chen P.-X. Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. Neurosci Lett 2006, 410:174-177.
61. Liu Y., Figley S., Spratt S.K., Lee G., Ando D., Surosky R., Fehlings M.G. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol Dis 2010, 37:384-393.
62. Loane D.J., Byrnes K.R. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7:366-377.
63. Ma Y., Liu W., Wang Y., Chao X., Qu Y., Wang K., Fei Z. VEGF protects rat cortical neurons from mechanical trauma injury induced apoptosis via the MEK/ERK pathway. Brain Res Bull 2011, 86:441-446.
64. Madinier A., Bertrand N., Mossiat C., Prigent-Tessier A., Beley A., Marie C., Garnier P. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009, 4:e8101.
65. Marsala M., Sorkin L.S., Yaksh T.L. Transient spinal ischemia in rat: characterization of spinal cord blood flow, extracellular amino acid release, and concurrent histopathological damage. J Cereb Blood Flow Metab 1994, 14:604-614.
66. Marsala M., Kakinohana O., Yaksh T.L., Tomori Z., Marsala S., Cizkova D. Spinal implantation of hNT neurons and neuronal precursors: graft survival and functional effects in rats with ischemic spastic paraplegia. Eur J Neurosci 2004, 20:2401-2414.
67. Marti H.H., Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A 1998, 95:15809-15814.
68. Martins A., Han J., Kim S.O. The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis. IUBMB Life 2010, 62:611-617.
69. McBride J.L., Ramaswamy S., Gasmi M., Bartus R.T., Herzog C.D., Brandon E.P., Zhou L., Pitzer M.R., Berry-Kravis E.M., Kordower J.H. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 2006, 103:9345-9350.
70. Meuer K., Pitzer C., Teismann P., Krüger C., Göricke B., Laage R., Lingor P., Peters K., Schlachetzki J.C.M., Kobayashi K., Dietz G.P.H., Weber D., Ferger B., Schäbitz W.-R., Bach A., Schulz J.B., Bähr M., Schneider A., Weishaupt J.H. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem 2006, 97:675-686.
71. Middeldorp J., Hol E.M. GFAP in health and disease. Prog Neurobiol 2011, 93:421-443.
72. Minnerup J., Sevimli S., Schabitz W.R. Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med 2009, 1:2.
73. Naganska E., Taraszewska A., Matyja E., Grieb P., Rafalowska J. Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study. Folia Neuropathol 2010, 48:35-44.
74. Nakata T., Kawachi K., Nagashima M., Yasugi T., Izutani H., Ryugo M., Okamura T., Shikata F., Imagawa H., Yano H., Takahashi H., Tanaka J. Transient ischemia-induced paresis and complete paraplegia displayed distinct reactions of microglia and macrophages. Brain Res 2011, 1420:114-124.
75. Nielsen J., Gotfryd K., Li S., Kulahin N., Soroka V., Rasmussen K.K., Bock E., Berezin V. Role of glial cell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF. J Neurosci 2009, 29:11360-11376.
76. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Dorpe J.V., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Bosch L.V.D., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.-M., Collen D., Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001, 28:131-138.
77. Panickar K.S., Norenberg M.D. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005, 50:287-298.
78. Paratcha G., Ledda F., Ibáñez C.F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 2003, 113:867-879.
79. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
80. Peppelenbosch N., Cuypers P.W., Vahl A.C., Vermassen F., Buth J. Emergency endovascular treatment for ruptured abdominal aortic aneurysm and the risk of spinal cord ischemia. J Vasc Surg 2005, Chapter 42:608-614.
81. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
82. Perry V.H., Nicoll J.A., Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 2010, 6:193-201.
83. Peters W., Rosner G., Ross M., Vredenburgh J., Meisenberg B., Gilbert C., Kurtzberg J. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993, 81:1709-1719.
84. Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 2011, 10:253-263.
85. Poesen K., Lambrechts D., Van Damme P., Dhondt J., Bender F., Frank N., Bogaert E., Claes B., Heylen L., Verheyen A., Raes K., Tjwa M., Eriksson U., Shibuya M., Nuydens R., Van Den Bosch L., Meert T., D'Hooge R., Sendtner M., Robberecht W., Carmeliet P. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci 2008, 28:10451-10459.
86. Polazzi E., Monti B. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 2010, 92:293-315.
87. Prewitt C.M.F., Niesman I.R., Kane C.J.M., Houlé J.D. Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 1997, 148:433-443.
88. Proescholdt M.A., Heiss J.D., Walbridge S., Mühlhauser J., Capogrossi M.C., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 1999, 58:613-627.
89. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998, 4:814-821.
90. Rosenblad C., Kirik D., Devaux B., Moffat B., Phillips H.S., Björklund A. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur J Neurosci 1999, 11:1554-1566.
91. Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011, 11:775-787.
92. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 1998, 95:4635-4640.
93. Sakowski S.A., Heavener S.B., Lunn J.S., Fung K., Oh S.S., Spratt S.K., Hogikyan N.D., Feldman E.L. Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Ther 2009, 16:1292-1299.
94. Satake K., Matsuyama Y., Kamiya M., Kawakami H., Iwata H., Adachi K., Kiuchi K. Up-regulation of glial cell line-derived neurotrophic factor (GDNF) following traumatic spinal cord injury. NeuroReport 2000, 11:3877-3881.
95. Savas S., Savas C., Altuntas I., Adiloglu A. The correlation between nitric oxide and vascular endothelial growth factor in spinal cord injury. Spinal Cord 2007, 46:113-117.
96. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., Sommer C., Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003, 34:745-751.
97. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schabitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005, 115:2083-2098.
98. Sehara Y., Hayashi T., Deguchi K., Zhang H., Tsuchiya A., Yamashita T., Lukic V., Nagai M., Kamiya T., Abe K. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res 2007, 1151:142-149.
99. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 2006, 7:194-206.
100. Shang J., Deguchi K., Ohta Y., Liu N., Zhang X., Tian F., Yamashita T., Ikeda Y., Matsuura T., Funakoshi H., Nakamura T., Abe K. Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J Neurosci Res 2011, 89:86-95.
101. Shen L.H., Li Y., Chopp M. Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats. Glia 2010, 58:1074-1081.
102. Sherer T.B., Fiske B.K., Svendsen C.N., Lang A.E., Langston J.W. Crossroads in GDNF therapy for Parkinson's disease. Mov Disord 2006, 21:136-141.
103. Shibuya M. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. FEBS J 2009, 276:4636-4643.
104. Shimazaki C., Oku N., Uchiyama H., Yamagata N., Tatsumi T., Hirata T., Ashihara E., Okawa K., Goto H., Inaba T., et al. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplant 1994, 13:271-275.
105. Silverman W.F., Krum J.M., Mani N., Rosenstein J.M. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 1999, 90:1529-1541.
106. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
107. Solaroglu I., Tsubokawa T., Cahill J., Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143:965-974.
108. Somlo G., Sniecinski I., ter Veer A., Longmate J., Knutson G., Vuk-Pavlovic S., Bhatia R., Chow W., Leong L., Morgan R., Margolin K., Raschko J., Shibata S., Tetef M., Yen Y., Forman S., Jones D., Ashby M., Fyfe G., Hellmann S., Doroshow J.H. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy. Blood 1999, 93:2798-2806.
109. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999, 19:5731-5740.
110. Sugama S., Takenouchi T., Sekiyama K., Kitani H., Hashimoto M. Immunological responses of astroglia in the rat brain under acute stress: interleukin 1 beta co-localized in astroglia. Neuroscience 2011, 192:429-437.
111. Sun Y., Jin K., Childs J.T., Xie L., Mao X.O., Greenberg D.A. Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice. J Cereb Blood Flow Metab 2004, 24:1146-1152.
112. Sun Y., Jin K., Childs J.T., Xie L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol 2006, 289:329-335.
113. Tai M.H., Cheng H., Wu J.P., Liu Y.L., Lin P.R., Kuo J.S., Tseng C.J., Tzeng S.F. Gene transfer of glial cell line-derived neurotrophic factor promotes functional recovery following spinal cord contusion. Exp Neurol 2003, 183:508-515.
114. Taira Y., Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996, 27:1850-1858.
115. Takeda M., Kawaguchi M., Kumatoriya T., Horiuchi T., Watanabe K., Inoue S., Konishi N., Furuya H. Effects of minocycline on hind-limb motor function and gray and white matter injury after spinal cord ischemia in rats. Spine 2011, 36:1919-1924. 1910.1097/BRS.1910b1013e3181ffda1929.
116. Tokumine J., Kakinohana O., Cizkova D., Smith D.W., Marsala M. Changes in spinal GDNF, BDNF, and NT-3 expression after transient spinal cord ischemia in the rat. J Neurosci Res 2003, 74:552-561.
117. van Neerven S., Joosten E.A., Brook G.A., Lambert C.A., Mey J., Weis J., Marcus M.A., Steinbusch H.W., van Kleef M., Patijn J., Deumens R. Repetitive intrathecal VEGF(165) treatment has limited therapeutic effects after spinal cord injury in the rat. J Neurotrauma 2010, 27:1781-1791.
118. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004, 35:1732-1737.
119. Wang J., Li G., Wang Z., Zhang X., Yao L., Wang F., Liu S., Yin J., Ling E.A., Wang L., Hao A. High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes. Neuroscience 2012, 202:58-68.
120. Wei F., Guo W., Zou S., Ren K., Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 2008, 28:10482-10495.
121. Welte K., Gabrilove J., Bronchud M.H., Platzer E., Morstyn G. Filgrastim (r-metHuG-CSF): the first 10years. Blood 1996, 88:1907-1929.
122. Xiao B.G., Lu C.Z., Link H. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection. J Cell Mol Med 2007, 11:1272-1290.
123. Xuan A., Long D., Li J., Ji W., Hong L., Zhang M., Zhang W. Neuroprotective effects of valproic acid following transient global ischemia in rats. Life Sci 2012, 90:463-468.
124. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976, 17:1031-1036.
125. Yanagisawa D., Kitamura Y., Takata K., Hide I., Nakata Y., Taniguchi T. Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in rats. Biol Pharm Bull 2008, 31:1121-1130.
126. Yang D.-Y., Chen Y.-J., Wang M.-F., Pan H.-C., Chen S.-Y., Cheng F.-C. Granulocyte colony-stimulating factor enhances cellular proliferation and motor function recovery on rats subjected to traumatic brain injury. Neurol Res 2010, 32:1041-1049.
127. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000, 106:829-838.